Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Nuclear Medicine

  Free Subscription


15.12.2025

1 Am J Cardiol
2 Ann Neurol
1 Ann Nucl Med
3 Appl Radiat Isot
3 Brain
45 Clin Nucl Med
1 J Cereb Blood Flow Metab
4 J Nucl Cardiol
15 J Nucl Med
3 Neurology
5 Nucl Med Commun
1 Phys Med Biol
1 PLoS One
3 Semin Nucl Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. NIIZEKI T, Iwayama T, Sasaki T
    Prognostic Implications of Regional Cerebral Blood Flow Abnormality Assessed by Single Photon Emission Computed Tomography in Chronic Heart Failure Patients.
    Am J Cardiol. 2025 Aug 21:S0002-9149(25)00482.
    PubMed         Abstract available


    Ann Neurol

  2. ABDELMOITY O, Wisch JK, Kennedy JT, Goyal M, et al
    Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease.
    Ann Neurol. 2025 Sep 22. doi: 10.1002/ana.78002.
    PubMed         Abstract available

  3. BACHMANN D, Wybitul M, Studer S, Saake A, et al
    Protective Effects of Socioeconomic Status and Lifestyle on Amyloid- and White Matter Hyperintensity-Related Longitudinal Brain Atrophy and Cognitive Decline.
    Ann Neurol. 2025;98:1222-1236.
    PubMed         Abstract available


    Ann Nucl Med

  4. KIND F, Nemer U, Bruggemann K, Jilg CA, et al
    Prognostic value of whole-body tumor SUV dispersion on baseline PSMA PET prior to PSMA radioligand therapy.
    Ann Nucl Med. 2025 Dec 5. doi: 10.1007/s12149-025-02139.
    PubMed        


    Appl Radiat Isot

  5. KEBEDE MT, Dawud JE, Kejela BT, Gannamo MP, et al
    Assessment of radiation protection against knowledge, attitude and practice in nuclear medicine facilities in Addis Ababa, Ethiopia.
    Appl Radiat Isot. 2025;229:112372.
    PubMed         Abstract available

  6. ANDRADE EMR, Silva ACM, Ferreira AV, Gontijo RMG, et al
    A prototype of a 3D-printed zoomorphic mouse model for small animal PET scanner calibration.
    Appl Radiat Isot. 2025;229:112362.
    PubMed         Abstract available

  7. LUKUMAN B, Murat H, Said MA, Yaakob Y, et al
    Impact of body-mass-index (BMI) on effective dose of whole-body [(18)F] fluorodeoxyglucose PET/CT examinations.
    Appl Radiat Isot. 2025;229:112349.
    PubMed         Abstract available


    Brain

  8. PESCOLLER J, Dewenter A, Dehsarvi A, Steward A, et al
    Cortical tau deposition promotes atrophy in connected white matter regions in Alzheimer's disease.
    Brain. 2025 Sep 12:awaf339. doi: 10.1093.
    PubMed         Abstract available

  9. ZHU GH, He R, Yang ZY, Wang TT, et al
    Compensatory roles of STT3A and ALG5 in glucose metabolism of aged macaque hippocampus.
    Brain. 2025;148:4416-4434.
    PubMed         Abstract available

  10. HVINGELBY VS, Terkelsen MH, Johnsen EL, Moller M, et al
    Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's disease.
    Brain. 2025;148:4508-4518.
    PubMed         Abstract available


    Clin Nucl Med

  11. ZHENG L, Zhou Z, Zhang K, Xie P, et al
    68 Ga-DOTATATE Uptake in Pulmonary Lymphangitic Carcinomatosis: A Rare Form of Metastasis in Pediatric Neuroblastoma.
    Clin Nucl Med. 2026;51:65-67.
    PubMed         Abstract available

  12. WANG H, Huang R, Huang J, Feng L, et al
    Mandibular Osteosarcoma Mimicking Bisphosphonate-associated Osteonecrosis on 99m Tc-MDP Bone Scan in a Patient With Breast Cancer.
    Clin Nucl Med. 2026;51:68-69.
    PubMed         Abstract available

  13. AMANO Y, Amano M, Tang X
    Oncocytoma of Parotid Gland With Marked Uptake of 99m Tc-ethyl Cysteinate Dimer.
    Clin Nucl Med. 2026;51:44-45.
    PubMed         Abstract available

  14. JINDAL S, Manna S, Shetty A, Dehdashti F, et al
    Superior Diagnostic Yield of 18F-rhPSMA-7.3 Compared With 18F-DCFPyL PET/CT for the Detection of Recurrent Prostate Cancer.
    Clin Nucl Med. 2025 Nov 10. doi: 10.1097/RLU.0000000000006200.
    PubMed         Abstract available

  15. ASADUROVA S, Simo M, Sarria S, Cordero E, et al
    PSMA PET/CT Reveals Pituitary Renal Cell Carcinoma Metastasis Mimicking Immune-Related Hypophysitis.
    Clin Nucl Med. 2025 Nov 17. doi: 10.1097/RLU.0000000000006224.
    PubMed         Abstract available

  16. MAO Y, Wang M, Zhang J, Wang Z, et al
    99mTc-RBC SPECT/CT Scintigraphy for Diagnosis of Small Intestinal Angiosarcoma: A Case Report.
    Clin Nucl Med. 2025 Nov 17. doi: 10.1097/RLU.0000000000006218.
    PubMed         Abstract available

  17. FAN M, Guo X, Liu G, Tian C, et al
    Exploratory Analysis of [68Ga]Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to [177Lu]Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer.
    Clin Nucl Med. 2025 Nov 18. doi: 10.1097/RLU.0000000000006210.
    PubMed         Abstract available

  18. KUMAR SA, Goyal H, Halanaik D
    68Ga-FAPI PET/CT in Disseminated Actinomycosis With Cardiac Infiltration.
    Clin Nucl Med. 2025 Nov 19. doi: 10.1097/RLU.0000000000006217.
    PubMed         Abstract available

  19. BHAT S, Agarwal KK, Patel S, Bhanarkar S, et al
    ECG-Gated FDG PET/CT as a Novel Tool in Diagnosis of Coronary Stent Infection.
    Clin Nucl Med. 2025 Nov 18. doi: 10.1097/RLU.0000000000006221.
    PubMed         Abstract available

  20. LIN X, Xie Y, Li W, Xu T, et al
    Visualization of the Gallbladder on 177Lu-FAP-2286 SPECT/CT Imaging: A Potential Pitfall.
    Clin Nucl Med. 2025 Nov 18. doi: 10.1097/RLU.0000000000006209.
    PubMed         Abstract available

  21. STEYER B, O'Brien SR, Pantel AR
    Hypercalcemia Secondary to Silicone Inflammation Shown on FDG PET/CT.
    Clin Nucl Med. 2025 Nov 19. doi: 10.1097/RLU.0000000000006215.
    PubMed         Abstract available

  22. YANG J, Pang S, Zhang C, Xie Y, et al
    68 Ga-Pentixafor Uptake in Collecting Duct Carcinoma.
    Clin Nucl Med. 2026;51:51-53.
    PubMed         Abstract available

  23. SAHAFI P, Samadi MH, Kiani MA, Mohammadipour A, et al
    Simultaneous Visualization of a Meckel Diverticulum and its Active Bleeding on Tc-99m-Pertechnetate Scintigraphy: An Unusual Presentation.
    Clin Nucl Med. 2026;51:e19-e20.
    PubMed         Abstract available

  24. LIU L, Chen L, Dong A, Jia G, et al
    Increased 68 Ga-FAPI-04 Uptake in Cerebral Infarction.
    Clin Nucl Med. 2026;51:73-75.
    PubMed         Abstract available

  25. KAR S, Lele VR, Shaikh N
    68 Ga-Trivehexin Uptake in Brown Tumors in Hyperparathyroidism : A Novel Finding.
    Clin Nucl Med. 2026;51:e46-e47.
    PubMed         Abstract available

  26. MARAFI F, Alahmad T, Alfeeli M, Sadeq A, et al
    Triple Negative Breast Cancer and 68 Ga-Trivehexin : A Glance of Hope.
    Clin Nucl Med. 2026;51:e50-e51.
    PubMed         Abstract available

  27. CHEN YY, Zhou YR, Jiang ZP, Wang SX, et al
    A Case of 99m Tc-Pyrophosphate Myocardial Scintigraphy Positivity in Fabry Disease.
    Clin Nucl Med. 2026;51:e65-e67.
    PubMed         Abstract available

  28. GHASEMIFARD A, Saber Tanha A, Rabani F, Behforouz A, et al
    99m Tc-PSMA Scintigraphy in Splenic Hemangioma.
    Clin Nucl Med. 2026;51:e68-e69.
    PubMed         Abstract available

  29. RAEISI N, Saber Tanha A, Khooei A, Ataei N, et al
    Favorable 99m Tc-FAPI-46 Uptake in Primary Mucinous Adenocarcinoma of the Bladder.
    Clin Nucl Med. 2026;51:e55-e56.
    PubMed         Abstract available

  30. SPEICHER T, Burgard C, Rosar F, Bastian M, et al
    Superior NET Targeting by Switch From Agonist to Antagonist-mediated Somatostatin Receptor Theranostics Allowing Successful (LM3-based) PRRT of Otherwise Precluded mNET: Intraindividual Proof-of-concept.
    Clin Nucl Med. 2026;51:e25-e26.
    PubMed         Abstract available

  31. RAEISI N, Saber Tanha A, Jafari Zarrin Ghabaei F, Aryana K, et al
    FAPI-avid Lesions in the Brain: A Case Report on 99m Tc-FAPI-46 Scintigraphy in Glioblastoma Multiforme.
    Clin Nucl Med. 2026;51:e29-e31.
    PubMed         Abstract available

  32. ALABED YZ, Ansari HA
    18 F-Fluorocholine Uptake in Unilateral Breast Related to Breastfeeding in Patient With Primary Hyperparathyroidism.
    Clin Nucl Med. 2026;51:e61-e62.
    PubMed         Abstract available

  33. SINGH B, Watts A, Kaur H, Kumar S, et al
    Current Status and Future Perspectives of CXCR4-based Radio-theranostics in Human Cancers: A Review.
    Clin Nucl Med. 2026;51:e72-e83.
    PubMed         Abstract available

  34. CHEN MY, Wang YF, Peng NJ, Lee TH, et al
    Radionuclide Cisternography Revealed Neck Cyst Formed by Cerebrospinal Fluid Leakage After Cervical Spine Surgery.
    Clin Nucl Med. 2026;51:63-64.
    PubMed         Abstract available

  35. FARAZMAND C, Attaseth P, Zhuang H
    Mesenteric Panniculitis Mimicking Metastases From Melanoma on FDG PET/CT in a Pediatric Patient Receiving Immunotherapy.
    Clin Nucl Med. 2026;51:57-60.
    PubMed         Abstract available

  36. HINTERBERGER A, Jakob J, Menge F, Davarci G, et al
    [68Ga]Ga-FAPI-46 PET/MRI for Therapy Monitoring of Desmoid Tumors.
    Clin Nucl Med. 2026;51:54-56.
    PubMed         Abstract available

  37. ZHOU Y, Hou Y, Yin C, Gai Y, et al
    FAPI PET in the Diagnosis and Management of Inflammatory Diseases: Clinical Value and Future Perspectives.
    Clin Nucl Med. 2026;51:35-43.
    PubMed         Abstract available

  38. LIGHT A, Lazic S, Connor MJ, Tam H, et al
    Validation of the PSMA PRIMARY Scoring System and Comparison to an E-PSMA Likert System for [68Ga]Ga-PSMA-11 PET/CT Interpretation in Men With Suspected Radiorecurrent Prostate Cancer.
    Clin Nucl Med. 2026;51:e1-e10.
    PubMed         Abstract available

  39. JIA C, Liang M, Zhang T, Li Q, et al
    Comparative [18F]Florzolotau and [18F]FDG PET Imaging Patterns in Anti-IgLON5 Disease and Progressive Supranuclear Palsy.
    Clin Nucl Med. 2026;51:28-34.
    PubMed         Abstract available

  40. WANG C, Kang T, Hu S, Shao Z, et al
    Biodistribution and Radiation Dosimetry of [18F]AlF-NSFBP4 in Cancer Patients: First-in-Human Study.
    Clin Nucl Med. 2026;51:21-27.
    PubMed         Abstract available

  41. WANG Y, Liu Z, Li Y, He K, et al
    [18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CT.
    Clin Nucl Med. 2026;51:2-12.
    PubMed         Abstract available

  42. COLLETTI PM
    50 Years of Clinical Nuclear Medicine.
    Clin Nucl Med. 2026;51:1.
    PubMed        

  43. KUANG G, Qiu Z, Li L, Liu Y, et al
    Contrasting Cerebral Hyperperfusion Patterns in Moyamoya Disease Versus Atherosclerotic Occlusive Cerebrovascular Disease: Insights From Day-One 99mTc-ECD SPECT After Revascularization.
    Clin Nucl Med. 2025 Nov 26. doi: 10.1097/RLU.0000000000006232.
    PubMed        

  44. KUNDU N, Sagar S, Khan D, Singh P, et al
    Preserving Fertility, Not Metastases: A Pediatric FDG PET/CT Diagnostic Challenge.
    Clin Nucl Med. 2025 Nov 21. doi: 10.1097/RLU.0000000000006229.
    PubMed         Abstract available

  45. SELVARAJ V, Gupta SD, Srivastava MK, Turaga S, et al
    Rabies Encephalitis on FDG PET CT: First Case of Metabolic Imaging in Rare Survivor.
    Clin Nucl Med. 2025 Nov 21. doi: 10.1097/RLU.0000000000006236.
    PubMed         Abstract available

  46. ATTASETH P, Davis JC, Zhuang H
    Rare Subcutaneous Manifestation of Rosai-Dorfman Disease on FDG PET/CT in an Adolescent.
    Clin Nucl Med. 2025 Nov 21. doi: 10.1097/RLU.0000000000006244.
    PubMed         Abstract available

  47. WANG R, Li Z, Wang L, Wei Z, et al
    Clinical Translation of a Dual Integrin-and GRPR-targeting PET Radiotracer 68Ga-DOTA-RGD-RM26 in Glioma.
    Clin Nucl Med. 2025 Nov 19. doi: 10.1097/RLU.0000000000006195.
    PubMed         Abstract available

  48. GULBAHAR ATES S, Aydos U, Balci E, Akdemir UO, et al
    Visual and Quantitative Analysis of 123I-Ioflupane SPECT Reveals Asymmetric Neuronal Degeneration in Fahr's Disease.
    Clin Nucl Med. 2025 Nov 20. doi: 10.1097/RLU.0000000000006243.
    PubMed         Abstract available

  49. FANG H, Tang A, Tang C, Lan X, et al
    Multimodal PET/MR Imaging in Early-onset Alzheimer's Disease With Parkinsonism due to a Novel Presenilin-1 (M233I) Mutation.
    Clin Nucl Med. 2025 Nov 21. doi: 10.1097/RLU.0000000000006238.
    PubMed         Abstract available

  50. PUROHIT P, Aggarwal P, Kumar R, Preet K, et al
    Exploring the Diagnostic Utility of 68Ga-FAPI-46 PET/CT in Diverse Pulmonary Pathologies: A Comparative Analysis With 18F-FDG PET/CT.
    Clin Nucl Med. 2025 Oct 24. doi: 10.1097/RLU.0000000000006186.
    PubMed         Abstract available

  51. SUN J, Luo Y, Gong W, Long H, et al
    18F-FAPI-42 PET/MRI in the Evaluation of Glioma Recurrence: Comparison With 11C-MET PET/MRI and Contrast-enhanced MRI.
    Clin Nucl Med. 2025 Dec 5. doi: 10.1097/RLU.0000000000006220.
    PubMed         Abstract available

  52. DAMBRAIN A, Le Bihan J, Lissillour PL, Buyse M, et al
    Lung Function Assessment of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Cystic Fibrosis Patients With Ventilation/Perfusion SPECT/CT.
    Clin Nucl Med. 2025 Nov 19. doi: 10.1097/RLU.0000000000006211.
    PubMed         Abstract available

  53. RABANI F, Saber Tanha A, Taheri F, Afshari N, et al
    Urinary Reflux Mimicking Seminal Vesicle Invasion on 99mTc-HYNIC-PSMA SPECT/CT: Clarification by Concurrent Bone Scintigraphy.
    Clin Nucl Med. 2025 Nov 19. doi: 10.1097/RLU.0000000000006235.
    PubMed         Abstract available

  54. AIT TALHIQ H, Baltzinger P, Achille M, Addeo P, et al
    Functional Evaluation of Irreversible Electroporation for a Pancreatic Nonfunctioning Neuroendocrine Tumor Using 68Ga-DOTATOC PET/CT.
    Clin Nucl Med. 2025 Nov 19. doi: 10.1097/RLU.0000000000006223.
    PubMed         Abstract available

  55. CHUNG SJ, Kim SH, Jeong SH, Lee HS, et al
    Prediction of Amyloid Positivity in Lewy Body Disease Using Early-Phase 18 F-FP-CIT PET Images.
    Clin Nucl Med. 2026;51:13-20.
    PubMed         Abstract available


    J Cereb Blood Flow Metab

  56. GIOVACCHINI G, Toczek MT, Lang L, Theodore WH, et al
    Quantification of 5-HT(1a) receptors in temporal lobe epilepsy with PET and [(18)F]FCWAY: Effect of modeling methods on group discrimination.
    J Cereb Blood Flow Metab. 2025 Dec 7:271678X251400245.
    PubMed         Abstract available


    J Nucl Cardiol

  57. VILAIN D, Cobes N, Girma A, Amar R, et al
    Regional Myocardial Uptake in Routine Oncologic (18)F-FDG PET/CT Studies and Coronary Artery Disease.
    J Nucl Cardiol. 2025 Dec 11:102592. doi: 10.1016/j.nuclcard.2025.102592.
    PubMed        

  58. MISHRA M, Taywade S, Kumar R, Patel S, et al
    A Case of Early Prosthetic Valve Endocarditis Complicated with Large Pseudoaneurysm: The Role of 18F-FDG PET/CT in Initial and Follow-up Evaluation.
    J Nucl Cardiol. 2025 Dec 11:102594. doi: 10.1016/j.nuclcard.2025.102594.
    PubMed        

  59. MANNAN ZM, Hankinson SJ, Laychak SS, Hainer J, et al
    Prevalence of Lateral Wall Myocardial FDG Uptake in Patients with Left Bundle Branch Block or Ventricular Pacing Referred for Sarcoidosis FDG PET/CT Imaging.
    J Nucl Cardiol. 2025 Dec 4:102581. doi: 10.1016/j.nuclcard.2025.102581.
    PubMed         Abstract available

  60. FUJITO H, Gransar H, Park RH, Han D, et al
    Dual Assessment of CAC and Exercise Ability Enhances Mortality Prediction in Stress SPECT-MPI Patients.
    J Nucl Cardiol. 2025 Dec 3:102582. doi: 10.1016/j.nuclcard.2025.102582.
    PubMed         Abstract available


    J Nucl Med

  61. MURTHY V, Kimura K, Theus L, Nguyen A, et al
    Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [(177)Lu]Lu-PSMA-617: A Single-Center Retrospective Study.
    J Nucl Med. 2025 Dec 4:jnumed.125.270916. doi: 10.2967/jnumed.125.270916.
    PubMed         Abstract available

  62. AUER B, De Moraes A, Pabon AJR, Clerc OF, et al
    Dynamic Acquisition of [(99m)Tc]Tc-Pyrophosphate SPECT/CT Images in Transthyretin Cardiac Amyloidosis: A Pilot Study.
    J Nucl Med. 2025 Dec 11:jnumed.125.270405. doi: 10.2967/jnumed.125.270405.
    PubMed         Abstract available

  63. TREVES ST, Fahey FH, Valencia VF, Burchell N, et al
    Summary of the 2024 Update of the North American Guidelines for Pediatric Administered Radiopharmaceutical Activities.
    J Nucl Med. 2025 Dec 4:jnumed.125.270478. doi: 10.2967/jnumed.125.270478.
    PubMed        

  64. HU Q, Zhang S, Yang K, Yin Y, et al
    (68)Ga-FAPI-04 PET for Detecting Occult Peritoneal Metastasis in Locally Advanced Gastric Cancer: Diagnostic Performance and Cost Analyses in a Single-Center, Prospective Cohort Study.
    J Nucl Med. 2025 Dec 4:jnumed.125.270633. doi: 10.2967/jnumed.125.270633.
    PubMed         Abstract available

  65. MAURER A, Muehlematter UJ, Sivakumar T, Mortezavi A, et al
    High-Intensity Focused Ultrasound in Prostate Cancer: Can PSMA PET Improve Focal Therapy Outcomes?
    J Nucl Med. 2025 Dec 4:jnumed.125.271318. doi: 10.2967/jnumed.125.271318.
    PubMed         Abstract available

  66. CHEN Y, Mintzer RA, Cho S, Pocci D, et al
    Development of a Prototype AWSM-PET Device for Augmented Whole-Body PET Imaging and Initial Human Study.
    J Nucl Med. 2025 Dec 4:jnumed.125.270117. doi: 10.2967/jnumed.125.270117.
    PubMed         Abstract available

  67. SPECHT JM, van Geel JJL, Song S, Liu C, et al
    The Role of Estrogen Receptor-Targeted PET with 16alpha-(18)F-Fluoro-17beta-Estradiol in Predicting Response to Endocrine Therapies in Metastatic Breast Cancer: A Metaanalysis.
    J Nucl Med. 2025 Dec 4:jnumed.125.270763. doi: 10.2967/jnumed.125.270763.
    PubMed         Abstract available

  68. BADING JR, Mortimer JE
    The Role of HER2 PET in Treatment of Breast Cancer.
    J Nucl Med. 2025 Dec 11:jnumed.125.271364. doi: 10.2967/jnumed.125.271364.
    PubMed        

  69. HEO GS, Nai YH, Otaegui JR, Yang S, et al
    Preclinical Evaluation of (64)Cu-LNTH-1363S to Detect Cardiac FAP-Positive Fibroblasts Using PET Imaging.
    J Nucl Med. 2025 Dec 11:jnumed.125.270555. doi: 10.2967/jnumed.125.270555.
    PubMed         Abstract available

  70. URSO L, Boschi A, Schillaci O, Filippi L, et al
    Illuminating Multiple Sclerosis: Next-Generation PET Tracers for Molecular Insights.
    J Nucl Med. 2025 Dec 11:jnumed.125.271204. doi: 10.2967/jnumed.125.271204.
    PubMed         Abstract available

  71. SONG J, Ye J
    Critical Evaluation of HER2 PET Imaging in Metastatic Breast Cancer: Addressing Key Challenges and Future Directions.
    J Nucl Med. 2025 Dec 11:jnumed.125.271101. doi: 10.2967/jnumed.125.271101.
    PubMed        

  72. BRINK A, Kleynhans J, Grigoryan A, Omar W, et al
    The Current Status of Nuclear Medicine in Africa.
    J Nucl Med. 2025 Dec 11:jnumed.125.271248. doi: 10.2967/jnumed.125.271248.
    PubMed         Abstract available

  73. VAN DEN BROEK SL, Bratteby K, Aguilar X, Tran TA, et al
    Radionuclide Selection Influences Imaging Outcomes in Immuno-PET with a Brain-Penetrating Anti-Amyloid-beta Antibody.
    J Nucl Med. 2025 Dec 11:jnumed.125.271194. doi: 10.2967/jnumed.125.271194.
    PubMed         Abstract available

  74. MA C, Cao M, Li L, Wu Q, et al
    CD70-Targeted [(18)F]RCCB6 Immuno-PET/CT for Diagnosing Clear Cell Renal Cell Carcinoma Metastases: A Prospective Study.
    J Nucl Med. 2025 Dec 11:jnumed.125.270958. doi: 10.2967/jnumed.125.270958.
    PubMed         Abstract available

  75. YEH R
    Reply: The Role of HER2 PET in Treatment of Breast Cancer.
    J Nucl Med. 2025 Dec 11:jnumed.125.271241. doi: 10.2967/jnumed.125.271241.
    PubMed        


    Neurology

  76. JUNG YH, Cho J, Lee SY, Seo HE, et al
    Impact of Cerebral Microbleeds on Tau-Associated Cognitive and Structural Decline.
    Neurology. 2026;106:e214453.
    PubMed         Abstract available

  77. FERREIRA PCL, Bellaver B, Povala G, Bauer-Negrini G, et al
    Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials.
    Neurology. 2026;106:e214441.
    PubMed         Abstract available

  78. LI CH, Fan SP, Chen PS, Chang YY, et al
    Plasma pTau217 and Neurofilament Light Chain as Differentiative Markers for Progressive Supranuclear Palsy From Parkinson Disease.
    Neurology. 2026;106:e214406.
    PubMed         Abstract available


    Nucl Med Commun

  79. HUA Y, Wang B, Su Q
    The relationship between posttreatment 18 F-fluorodeoxyglucose PET/computed tomography restaging and metabolic parameters with the prognosis of uterine cervical cancer.
    Nucl Med Commun. 2025 Dec 12. doi: 10.1097/MNM.0000000000002093.
    PubMed         Abstract available

  80. LAWLOR K, King S
    Should gastric emptying scintigraphy studies be performed, as standard, on paediatric patients with suspected gastroparesis? A systematic literature review.
    Nucl Med Commun. 2026;47:11-19.
    PubMed         Abstract available

  81. ROMERO-FARINA G, Aguade-Bruix S, Palomar-Munoz A, Diez-Castro MJ, et al
    A novel ventricular systolic workload index enhances prognostic evaluation using gated single photon emission computed tomography in patients with suspected coronary artery disease.
    Nucl Med Commun. 2026;47:69-78.
    PubMed         Abstract available

  82. ABDULLAHI F, Makhdomi K, Shah J, Gitau S, et al
    Prolonged fasting for optimizing myocardial fluorodeoxyglucose suppression.
    Nucl Med Commun. 2026;47:99-104.
    PubMed         Abstract available

  83. JONMARKER O, Sunderland M, Steffens L, Samuelsson C, et al
    Retrospective analysis of [ 99m Tc]Tc-HYNIC-PSMA single photon emission computed tomography CT in patients with prostate cancer.
    Nucl Med Commun. 2026;47:41-48.
    PubMed         Abstract available


    Phys Med Biol

  84. AMINI M, Saberi Manesh A, Doroud K, Arabi H, et al
    A compact depth-of-interaction time-of-flight detector panel dedicated for organ-specific PET scanner.
    Phys Med Biol. 2025 Dec 10. doi: 10.1088/1361-6560.
    PubMed         Abstract available


    PLoS One

  85. KARUNA Y, Allapakam V, Priyanka S, Hussian SR, et al
    Brain tumour segmentation in fused MRI-PET images with permutate U-Net framework.
    PLoS One. 2025;20:e0335952.
    PubMed         Abstract available


    Semin Nucl Med

  86. BENTESTUEN M, Dahlsgaard-Wallenius S, Stolberg MMK, Zacho HD, et al
    Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00168.
    PubMed         Abstract available

  87. SAFARIAN A, Muin D, Unterrainer L, Hormann A, et al
    The role of non-FDG agents in PET imaging of bladder cancer.
    Semin Nucl Med. 2025 Dec 8:S0001-2998(25)00165.
    PubMed         Abstract available

  88. RIZZO A, Treglia G
    PSMA PET in renal cell carcinoma: an update and future aspects.
    Semin Nucl Med. 2025 Dec 3:S0001-2998(25)00166.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.